NOVAVAX INC: accounts_payable
| Value | {"amount": 16101000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2026-03-31) |
| Status | current |
| Entity | NOVAVAX INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:06.826654+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d5766b90-4e24-47a4-ba1a-6c04a8805131
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-26-030917Retrieved: 2026-08-19T09:41:06.826654+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001000694/accounts-payable/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d5766b90-4e24-47a4-ba1a-6c04a8805131
History
- no predecessors — first report